To include your compound in the COVID-19 Resource Center, submit it here.

Symbicort budesonide/formoterol: Phase III data

A double-blind, U.S. Phase III trial in 742 self-reported African Americans ages 12 and older with moderate to severe persistent asthma showed

Read the full 229 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE